Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_65aff616cbe92e32636fbb3e75d9921a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-364 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate |
2020-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9d17c245cbce7cd3cd316d5d9478fd7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed1548575da47781c53ee72abfaedf54 |
publicationDate |
2022-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-114144673-A |
titleOfInvention |
S100A8 as a blood biomarker for non-invasive diagnosis of endometriosis |
abstract |
The present invention relates to assessing whether a patient has endometriosis or is at risk of developing endometriosis by determining the amount or concentration of S100A8 in a sample of the patient and comparing the determined amount or concentration to a reference , methods of selecting patients for therapy, and methods of monitoring patients with endometriosis or undergoing treatment for endometriosis. |
priorityDate |
2019-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |